Hiroshi Yasui Selected Research

Hiroshi Yasui Research Topics

Disease

37	Multiple Myeloma 01/2023 - 11/2004
28	Neoplasms (Cancer) 12/2023 - 03/2003
4	Carcinoma (Carcinomatosis) 11/2018 - 03/2003
3	Hemorrhage 07/2023 - 03/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2005
3	Neoplasm Metastasis (Metastasis) 11/2018 - 06/2003
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2009
3	Necrosis 02/2007 - 04/2005
2	Anemia 07/2023 - 04/2005
2	Adenocarcinoma 08/2019 - 02/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2019 - 12/2006
2	Hematoma 09/2012 - 01/2003
2	Immunoglobulin Light-chain Amyloidosis 09/2012 - 11/2007
2	Stomach Neoplasms (Stomach Cancer) 09/2012 - 05/2009
2	Plasmacytoma 03/2011 - 05/2006
2	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 06/2010 - 01/2003
1	Malignant Mesothelioma 12/2023
1	False Aneurysm (Pseudoaneurysm) 07/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021
1	Pathologic Complete Response 01/2021
1	Neutropenia 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Malaria 01/2021
1	Hematologic Diseases (Blood Diseases) 10/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2019
1	Multiple Pulmonary Nodules 11/2018

Drug/Important Bio-Agent (IBA)

12	Bortezomib (Velcade)FDA Link 01/2021 - 04/2005
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 04/2005
7	Interleukin-6 (Interleukin 6)IBA 02/2007 - 11/2004
4	Lenalidomide (CC 5013)FDA Link 01/2023 - 11/2012
4	Immunomodulating AgentsIBA 01/2017 - 01/2005
4	Thalidomide (Thalomid)FDA Link 01/2017 - 01/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2007 - 11/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2006 - 03/2003
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2006
3	SurvivinIBA 08/2019 - 09/2007
3	Proteasome InhibitorsIBA 01/2017 - 11/2005
3	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 06/2007
3	Cisplatin (Platino)FDA LinkGeneric 11/2014 - 05/2009
3	Melphalan (Alkeran)FDA LinkGeneric 11/2007 - 10/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2007 - 07/2005
3	CaspasesIBA 02/2007 - 09/2005
3	CytokinesIBA 10/2006 - 11/2004
2	LipidsIBA 12/2023 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2014
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 05/2009
2	LigandsIBA 08/2019 - 02/2005
2	Peptides (Polypeptides)IBA 08/2019 - 08/2019
2	AntibodiesIBA 09/2018 - 08/2005
2	Immunoglobulin G (IgG)IBA 07/2014 - 10/2011
2	Amyloid (Amyloid Fibrils)IBA 09/2012 - 11/2007
2	Monoclonal AntibodiesIBA 05/2011 - 06/2009
2	Phosphotransferases (Kinase)IBA 06/2008 - 11/2004
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2006 - 08/2005
2	Etodolac (Lodine)FDA LinkGeneric 07/2006 - 07/2005
2	Insulin-Like PeptidesIBA 02/2006 - 09/2005
2	InterleukinsIBA 02/2006 - 11/2004
2	Indicators and Reagents (Reagents)IBA 01/2006 - 03/2003
2	Antineoplastic Agents (Antineoplastics)IBA 02/2005 - 03/2003
2	NF-kappa B (NF-kB)IBA 12/2003 - 03/2003
2	Sulindac (Copal)FDA LinkGeneric 12/2003 - 03/2003
2	Transcription Factors (Transcription Factor)IBA 12/2003 - 03/2003
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 12/2023
1	Calbindin 2IBA 12/2023
1	DesminIBA 12/2023
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2023
1	MetalsIBA 07/2023
1	Interferon Regulatory FactorsIBA 01/2023
1	Trans-Activators (Trans-Acting Factor)IBA 01/2023
1	UbiquitinIBA 01/2023
1	venetoclaxIBA 11/2021
1	MTOR InhibitorsIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 11/2021
1	fms-Like Tyrosine Kinase 3IBA 04/2021
1	gilteritinibIBA 04/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	carfilzomibIBA 01/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	SterolsIBA 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021
1	CholesterolIBA 01/2021
1	CamptothecinIBA 01/2021
1	tegafur-gimeracil-oteracilIBA 08/2019
1	Protein Subunit VaccinesIBA 08/2019
1	Gemcitabine FDA Link 08/2019
1	Immune Checkpoint InhibitorsIBA 08/2019
1	ibrutinibIBA 03/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2019

Therapy/Procedure

17	Therapeutics 01/2021 - 01/2003
9	Drug Therapy (Chemotherapy) 07/2023 - 12/2006
3	Stem Cell Transplantation 06/2014 - 03/2011
2	Aftercare (After-Treatment) 01/2021 - 01/2018
2	Nephrectomy 11/2018 - 06/2003
2	Hematopoietic Stem Cell Transplantation 02/2016 - 06/2014
2	Hepatectomy 09/2012 - 06/2003
2	Gastrectomy 09/2012 - 03/2008
1	Stents 07/2023
1	Precision Medicine 12/2021
1	Immunotherapy 03/2021